Curio Digital Therapeutics, a company specializing in digital therapeutics for women’s health, has raised a ‘double digit million’ investment in its latest funding round. The round included investments from RYSE Asset Management, ONCE (the nutraceuticals venture capital arm of Otsuka), Bridge Point Capital, and Avestria. Curio, based in New Jersey, focuses on addressing mental health conditions such as postpartum depression (PPD) through…
BoobyBiome, a biotechnology company focused on infant health, has secured a £1.6 million Biomedical Catalyst grant from Innovate UK. The funding will support the testing and scale-up of BoobyBiome’s Synbiotic, a product developed from breast milk to improve gut health in infants. “We are delighted to receive this substantial grant from Innovate UK,” stated Dr. Lydia Mapstone, CEO and Co-founder of BoobyBiome.…
A new study conducted by Quest Diagnostics in collaboration with the University of Alabama has revealed significant gaps in the testing and treatment of sexually transmitted infections (STIs) among pregnant women in the United States. The study, titled Chlamydia and gonorrhea testing in pregnancy: Time to improve adherence and update recommendations, was published in the ‘Journal of Lower Genital Tract Disease’ and…
Needed, a company dedicated to improving perinatal nutrition, has launched Needed Academy, an Instagram-based educational program designed to address the critical need for accurate information on fertility, pregnancy, and postpartum health. Needed Academy is an educational platform specifically created for health practitioners, advocates, and influencer partners associated with Needed. The program responds to the widespread issue of outdated and inaccurate health information…
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on novel treatments for severe ischemic diseases, has announced the initiation of a Phase 2 trial for their preeclampsia treatment, DM199. This announcement came alongside their second quarter 2024 financial results and business update. Preeclampsia (PE) is a serious pregnancy complication characterized by high blood pressure and damage to organ systems, often affecting the kidneys…
Johnson & Johnson has announced significant findings from their Phase 2 UNITY study of nipocalimab for the treatment of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn (HDFN). The results, published in The New England Journal of Medicine, indicate that nipocalimab can delay or prevent severe fetal anemia and improve birth outcomes. HDFN occurs…
Materna Medical has announced the publication of clinical results in the International Urogynecology Journal. The study, titled “Effect of an intrapartum pelvic dilator device on levator ani muscle avulsion during primiparous vaginal delivery: A pilot randomized controlled trial,” highlights the safety and effectiveness of Materna’s Prep Device in reducing childbirth-related pelvic floor injuries in first-time mothers. The study reports that the use…
Babylist, a platform trusted by millions of growing families for its wide range of products and services across commerce, media, and health, has announced an expansion of its health offerings. This move aims to provide expecting and new parents with easier and more transparent access to health and wellness products during pregnancy and postpartum. The expansion includes broader coverage with breast pump…
